Sphere Bio Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024 News Sphere Bio Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024
Cyto-Cellect® PLUS launched to accelerate cell line development workflows News Cyto-Cellect® PLUS launched to accelerate cell line development workflows
Curtis Nicholson appointed as Director of Sales, EMEA, to support accelerated growth in key markets News Curtis Nicholson appointed as Director of Sales, EMEA, to support accelerated growth in key markets
Dale Levitzke appointed as Chief Executive Officer News Dale Levitzke appointed as Chief Executive Officer
Edward Rayner appointed as Non-Executive Director News Edward Rayner appointed as Non-Executive Director
Dr. Graeme Daniels appointed as Vice President of Sales and Marketing News Dr. Graeme Daniels appointed as Vice President of Sales and Marketing
Cyto-Mine® selected by FairJourney Biologics to advance cell line development workflows News Cyto-Mine® selected by FairJourney Biologics to advance cell line development workflows
Cyto-Mine® capabilities expanded to meet cGMP requirements for drug manufacture workflows News Cyto-Mine® capabilities expanded to meet cGMP requirements for drug manufacture workflows
Biosyntia chooses Pico-Mine® platform to accelerate synthetic biology and metabolic workflows News Biosyntia chooses Pico-Mine® platform to accelerate synthetic biology and metabolic workflows
Brand identity update aligns ambitious, global commercial growth strategy News Brand identity update aligns ambitious, global commercial growth strategy
